Stockreport

This Biotech Stock Dived Nearly 15% After Analyst Cuts To Sell Rating [Investor's Business Daily]

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Related news Acorda Therapeutics ( ACOR ) plunged Tuesday after an analyst downgraded the stock, suggesting multiple sclerosis treatment Ampyra will face "significant e [Read more]